16.47 USD
+0.46 (+2.87%)
17.87 USD
+1.4 (+8.5%)
ChartMill assigns a Buy % Consensus number of 68% to ONEM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.55. This target is 12.6% above the current price.
ONEM was analyzed by 20 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about ONEM.
In the previous month the buy percentage consensus was at a similar level.
ONEM was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-10-27 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2022-08-15 | Jefferies | Downgrade | Buy -> Hold |
| 2022-07-27 | Stifel | Downgrade | Buy -> Hold |
| 2022-07-25 | Truist Securities | Downgrade | Buy -> Hold |
| 2022-07-22 | BTIG | Downgrade | Buy -> Neutral |
| 2022-07-22 | Deutsche Bank | Maintains | Hold |
| 2022-07-22 | SVB Leerink | Maintains | Market Perform |
| 2022-07-22 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2022-07-22 | Citigroup | Downgrade | Buy -> Neutral |
| 2022-07-12 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2022-07-11 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-07-07 | BTIG | Upgrade | Neutral -> Buy |
| 2022-05-27 | Stifel | Initiate | Buy |
| 2022-05-09 | SVB Leerink | Maintains | Market Perform |
| 2022-05-05 | Citigroup | Maintains | Buy |
| 2022-02-25 | Deutsche Bank | Maintains | Buy |
| 2022-02-24 | Keybanc | Maintains | Overweight |
| 2022-02-24 | SVB Leerink | Maintains | Market Perform |
| 2022-02-24 | Morgan Stanley | Maintains | Overweight |
| 2022-02-24 | Piper Sandler | Maintains | Overweight |
| 2021-12-21 | JP Morgan | Maintains | Overweight |
| 2021-12-15 | Credit Suisse | Maintains | Outperform |
| 2021-11-09 | SVB Leerink | Maintains | Market Perform |
| 2021-11-04 | Keybanc | Maintains | Overweight |
| 2021-09-27 | SVB Leerink | Initiate | Market Perform |
| 2021-08-12 | Barclays | Initiate | Overweight |
| 2021-08-09 | Baird | Downgrade | Outperform -> Neutral |
| 2021-08-05 | Keybanc | Maintains | Overweight |
| 2021-08-05 | Canaccord Genuity | Maintains | Buy |
| 2021-06-29 | Canaccord Genuity | Maintains | Buy |
1LIFE HEALTHCARE INC / ONEM FAQ
What do analysts expect the price target to be for 1LIFE HEALTHCARE INC (ONEM)?
20 analysts have analysed ONEM and the average price target is 18.55 USD. This implies a price increase of 12.6% is expected in the next year compared to the current price of 16.47.
Can you provide the consensus rating for 1LIFE HEALTHCARE INC stock?
The consensus rating for 1LIFE HEALTHCARE INC (ONEM) is 68 / 100 . This indicates that analysts generally have a neutral outlook on the stock.